Mayo Clinic has initiated a formal leadership succession process following the decision of President and CEO Gianrico Farrugia to complete his tenure at the end of this year. According to the organization’s bylaws, the Board of Trustees will hold an election for the next chief executive in November, allowing for a coordinated transition on January 1, 2027. Board Chair Richard Davis confirmed that the formal transition process is underway, stating that Farrugia's leadership has "strengthened our ability to innovate, collaborate and meet the evolving needs of patients around the world."
Farrugia originally assumed the role of president and CEO in January 2019. Prior to leading the institution, his administrative work navigated substantial external change and directed the acceleration of disease treatment discoveries. Reflecting on his tenure, Farrugia stated, "Serving as president and CEO has been a true privilege, and I am certain that our momentum will continue." During his leadership, the organization was also recognized by Newsweek as the world’s best hospital for eight consecutive years.
The upcoming transition tasks the future leader with driving Mayo Clinic's “Bold. Forward.” strategy. This includes accelerating the discovery, translation, and delivery of cures for chronic and acute diseases, connecting people with data to create new knowledge, and managing the organization's first scalable, AI-enabled care transformation platform, known as Mayo Clinic Platform. The Board of Trustees stated that throughout the executive change, the institution remains grounded in its focus on delivering care, advancing discovery, and educating future generations.